{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:13:26Z","timestamp":1793726006858,"version":"4.6.1"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100006364","name":"French National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.radonc.2026.111533","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T23:45:47Z","timestamp":1778888747000},"page":"111533","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["OLIGOPELVIS 2-GETUG P12- elective nodal radiotherapy for oligorecurrent pelvic\/para-aortic nodes in prostate cancer: early toxicity of a randomized phase 3 trial"],"prefix":"10.1016","volume":"220","author":[{"given":"Hugo","family":"Corda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Blanc-Lapierre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-4608-2888","authenticated-orcid":false,"given":"Gr\u00e9goire","family":"Pigne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lysian","family":"Cartier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6019-7309","authenticated-orcid":false,"given":"David","family":"Pasquier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Ronchin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9266-8638","authenticated-orcid":false,"given":"Guillaume","family":"Bera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Hasbini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0872-5959","authenticated-orcid":false,"given":"Benjamin","family":"Schipman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Khalifa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Sargos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magali","family":"Quivrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Schick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Mallet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecile","family":"Laude","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clotilde","family":"Morand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1554-0646","authenticated-orcid":false,"given":"Genevi\u00e8ve","family":"Loos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loig","family":"Vaugier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Mesgouez-Nebout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2094-1708","authenticated-orcid":false,"given":"St\u00e9phane","family":"Supiot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2026.111533_b0005","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/nrurol.2016.175","article-title":"Oligometastatic prostate cancer: definitions, clinical outcomes, and treatment considerations","volume":"14","author":"Tosoian","year":"2017","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.radonc.2026.111533_b0010","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.19819","article-title":"Surgery, radiotherapy and endocrine therapy for oligometastatic prostate cancer efficacy: a systematic review and network meta-analysis","volume":"13","author":"Ying","year":"2025","journal-title":"PeerJ"},{"key":"10.1016\/j.radonc.2026.111533_b0015","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2017.75.4853","article-title":"Surveillance or metastasis-directed therapy for oligometastatic prostate cancer recurrence: a prospective, randomized, multicenter phase II Trial","author":"Ost","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2026.111533_b0020","article-title":"Narrative Review of PET\/CT Performances at Biochemical Recurrence in Prostate Cancer after Radical Prostatectomy and Impact on Patient Disease Management","volume":"32","author":"Lasserre","year":"2022","journal-title":"Prog En Urol"},{"key":"10.1016\/j.radonc.2026.111533_b0025","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.3390\/diagnostics12123176","article-title":"Recurrent Prostate Cancer Diagnostics with 18F-PSMA-1007 PET\/CT: a Systematic Review of the Current State","volume":"12","author":"Saule","year":"2022","journal-title":"Diagnostics"},{"key":"10.1016\/j.radonc.2026.111533_b0030","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.ijrobp.2016.11.014","article-title":"Patterns of Recurrence after Postprostatectomy Fossa Radiation Therapy Identified by C-11 Choline Positron Emission Tomography\/Computed Tomography","volume":"97","author":"Parker","year":"2017","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.radonc.2026.111533_b0035","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.radonc.2014.03.008","article-title":"Pattern of Occult Nodal Relapse Diagnosed with 18F-fluoro-choline PET\/CT in Prostate Cancer patients with Biochemical failure after Prostate-only Radiotherapy","volume":"111","author":"L\u00e9pinoy","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111533_b0040","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.eururo.2023.10.012","article-title":"The Efficacy and Safety of Metastasis-Directed Therapy in patients with Prostate Cancer: a Systematic Review and Meta-Analysis of prospective Studies","volume":"85","author":"Miszczyk","year":"2024","journal-title":"Eur Urol"},{"key":"10.1016\/j.radonc.2026.111533_b0045","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S1470-2045(25)00197-4","article-title":"Salvage Metastasis-Directed Therapy versus Elective Nodal Radiotherapy for Oligorecurrent Nodal Prostate Cancer Metastases (PEACE V\u2013STORM): a phase 2, Open-Label","volume":"26","author":"Ost","year":"2025","journal-title":"Randomised Controlled Trial Lancet Oncol"},{"key":"10.1016\/j.radonc.2026.111533_b0050","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.adro.2020.04.022","article-title":"A Novel Salvage Option for local failure in Prostate Cancer, Reirradiation using External Beam or Stereotactic Radiation Therapy: Systematic Review and Meta-Analysis","volume":"5","author":"Corkum","year":"2020","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.radonc.2026.111533_b0055","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/bju.13510","article-title":"Toxicity and Efficacy of Salvage Carbon 11-Choline Positron Emission Tomography\/Computed Tomography-Guided Radiation Therapy in patients with Lymph Node Recurrence of Prostate Cancer","volume":"119","author":"Fodor","year":"2017","journal-title":"BJU Int"},{"key":"10.1016\/j.radonc.2026.111533_b0060","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.canrad.2014.07.153","article-title":"Salvage Reirradiation for Locoregional failure after Radiation Therapy for Prostate Cancer: who, when, where and how?","volume":"18","author":"Cr\u00e9hange","year":"2014","journal-title":"Cancer\/Radioth\u00e9rapie"},{"key":"10.1016\/j.radonc.2026.111533_b0065","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.eururo.2021.06.010","article-title":"OLIGOPELVIS GETUG P07, a Multicenter phase II Trial of combined High-Dose Salvage Radiotherapy and Hormone Therapy in Oligorecurrent Pelvic Node Relapses in Prostate Cancer","volume":"80","author":"Supiot","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.radonc.2026.111533_b0070","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.ctrv.2015.10.005","article-title":"Definition of Lymph Node areas for Radiotherapy of Prostate Cancer: a critical Literature Review by the French Genito-Urinary Group and the French Association of Urology (GETUG-AFU)","volume":"41","author":"Sargos","year":"2015","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.radonc.2026.111533_b0075","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ijrobp.2009.02.006","article-title":"Development of RTOG consensus guidelines for the definition of the clinical target volume for postoperative conformal radiation therapy for prostate cancer","volume":"76","author":"Michalski","year":"2010","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.radonc.2026.111533_b0080","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.ijrobp.2008.08.002","article-title":"RTOG GU Radiation Oncology specialists Reach Consensus on Pelvic Lymph Node Volumes for High-Risk Prostate Cancer","volume":"74","author":"Lawton","year":"2009","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.radonc.2026.111533_b0085","doi-asserted-by":"crossref","unstructured":"Vaugier, L.; Chiavassa, S.; Alexis, A.; Guimas, V.; Dupuis, P.; Ayadi, M.; Blanc-Lapierre, A.; Delpon, G.; Supiot, S. Cumulative Dose Analysis Following Elective Pelvis Re-Irradiation at Junction with Primary Prostate Radiotherapy from the OLIGOPELVIS GETUG P07 Trial. Radiother. Oncol. Doi: 10.1016\/j.radonc.2026.111476.","DOI":"10.1016\/j.radonc.2026.111476"},{"key":"10.1016\/j.radonc.2026.111533_b0090","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ijrobp.2009.05.006","article-title":"Clinical Application of High-Dose, Image-Guided Intensity-Modulated Radiotherapy in High-Risk Prostate Cancer","volume":"77","author":"Bayley","year":"2010","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.radonc.2026.111533_b0095","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ijrobp.2010.09.018","article-title":"Phase I Trial of Pelvic Nodal Dose Escalation with Hypofractionated IMRT for High-Risk Prostate Cancer","volume":"82","author":"Adkison","year":"2012","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.radonc.2026.111533_b0100","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.euo.2023.09.007","article-title":"PEACE V\u2014Salvage Treatment of Oligo Recurrent Nodal Prostate Cancer Metastases (STORM): Acute Toxicity of a Randomized phase 2 Trial","volume":"7","author":"Ost","year":"2024","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.radonc.2026.111533_b0105","doi-asserted-by":"crossref","first-page":"S480","DOI":"10.1016\/S0167-8140(22)02388-X","article-title":"MO-0554 pelvic dose accumulation from time-successive prostate and lymph Node Radiation (NCT02274779)","volume":"170","author":"Vaugier","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111533_b0110","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.ijrobp.2022.05.040","article-title":"Para-Aortic Radiation Therapy for Oligorecurrent Prostate Cancer","volume":"114","author":"Rich","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111533_b0115","article-title":"Parallel phase II Trial of Hypofractionated Proton Therapy or IMRT for Recurrent, Oligometastatic Prostate Cancer with Pelvic and\/or Para-Aortic Lymph Node Involvement following Primary Localized Treatment with Radiotherapy","volume":"123 (1, Supplement), S83","author":"Davis","year":"2025","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.radonc.2026.111533_b0120","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/bju.13510","article-title":"Toxicity and Efficacy of Salvage Carbon 11\u2010choline Positron Emission Tomography\/Computed Tomography\u2010guided Radiation Therapy in patients with Lymph Node Recurrence of Prostate Cancer","volume":"119","author":"Fodor","year":"2017","journal-title":"BJU Int"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814026003725?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814026003725?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T12:47:46Z","timestamp":1783169266000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814026003725"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":24,"alternative-id":["S0167814026003725"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2026.111533","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"OLIGOPELVIS 2-GETUG P12- elective nodal radiotherapy for oligorecurrent pelvic\/para-aortic nodes in prostate cancer: early toxicity of a randomized phase 3 trial","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2026.111533","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111533"}}